Search Results
Phase IIb ELAD trial of liraglutide in mild-moderate Alzheimer’s disease
John Didsbury, PhD: Phase IIa Trial of T3D-959 in Mild to Moderate Alzheimer Disease
New Alzheimer Disease Clinical Trial: Semaglutide for Alzheimer Disease
The potential of lecanemab for the treatment of early Alzheimer’s disease
The Dr. Fred Show — [BREAKING] Ozempic for Alzheimer’s and Parkinson’s?
Detecting microglial activation in Alzheimer’s disease
HealthDay Now: Experts Weigh In On Alzheimer's Drug Controversy
Liraglutide 3.0 mg: Filling the gap in obesity management - Prof Inass Shaltout
Geriatric Grand Rounds, Savitha Subramanian, MD, April 16, 2021
Antidiabetic agents in Alzheimer’s disease - video abstract 74042
ENDO 2021 Press Conference: Obesity
ADDF WPB Pre-Luncheon Discussion 2020
![The Dr. Fred Show — [BREAKING] Ozempic for Alzheimer’s and Parkinson’s?](https://img.youtube.com/vi/IUPjKOTuVic/hqdefault.jpg)
